​
​

IGM Biosciences (IGMS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

IGM Biosciences Revenue Highlights

Latest Revenue (Y)

$2.13M

Latest Revenue (Q)

$516.00K

IGM Biosciences Revenue by Period

IGM Biosciences Revenue by Year

DateRevenueChange
2023-12-31$2.13M99.25%
2022-12-31$1.07M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

IGM Biosciences generated $2.13M in revenue during NA 2023, up 99.25% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

IGM Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30$516.00K-58.85%
2024-06-30$1.25M152.31%
2024-03-31$497.00K-23.66%
2023-12-31$651.00K27.90%
2023-09-30$509.00K13.62%
2023-06-30$448.00K-14.18%
2023-03-31$522.00K40.32%
2022-12-31$372.00K12.39%
2022-09-30$331.00K-9.56%
2022-06-30$366.00K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

IGM Biosciences generated $516.00K in revenue during Q3 2024, up -58.85% compared to the previous quarter, and up 115.18% compared to the same period a year ago.

IGM Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOWLWerewolf Therapeutics$19.94M$1.14M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
RNAAvidity Biosciences$9.56M$2.04M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
IGMSIGM Biosciences$2.13M$516.00K
BCELAtreca$770.00K$80.00K
DSGNDesign Therapeutics--
CGEMCullinan Oncology--
BDTXBlack Diamond Therapeutics--
GRCLGracell Bio--
CERECerevel Therapeutics--
ERASErasca--
PASGPassage Bio--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M

IGMS Revenue FAQ

What is IGM Biosciences’s yearly revenue?

IGM Biosciences's yearly revenue for 2023 was $2.13M, representing an increase of 99.25% compared to 2022. The company's yearly revenue for 2022 was $1.07M, representing an increase of 100.00% compared to 2021. IGMS's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is IGM Biosciences’s quarterly revenue?

IGM Biosciences's quarterly revenue for Q3 2024 was $516K, a -58.85% decrease from the previous quarter (Q2 2024), and a 1.38% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.25M, a 152.31% increase from the previous quarter (Q1 2024), and a 179.91% increase year-over-year (Q2 2023). IGMS's quarterly revenue for Q1 2024 was $497K, a -23.66% decrease from the previous quarter (Q4 2023), and a -4.79% decrease year-over-year (Q1 2023).

What is IGM Biosciences’s revenue growth rate?

IGM Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.